Search Blog
Categories
February 2018
M T W T F S S
« Jan   Mar »
 1234
567891011
12131415161718
19202122232425
262728  

Tags

MARCH 5 DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm

ACCESSWIRE

By The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / February 28, 2018 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ekso Bionics Holdings, Inc. (“Ekso” or the “Company”) (NASDAQ: EKSO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s shares between March 15, 2017, through December 27, 2017, inclusive (the “Class Period”), are encouraged to contact the firm before March 5, 2018, the lead plaintiff motion deadline.

If you are a shareholder who suffered a loss during the Class Period, click here to participate.

We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the complaint, the Company failed to disclose that: (1) there was a material weakness in Ekso’s internal control over financial reporting and Ekso’s disclosure controls and procedures were not effective; and (2) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
Sherin Mahdavian, Esq.
The Schall Law Firm

SOURCE: The Schall Law Firm

ReleaseID: 491265